Please be advised
In light of the public health emergency declared for the Novel Coronavirus, visitors to FDA campuses and buildings may be asked questions related to recent international travel.
Featured Topics
FDA’s Technology Modernization Action Plan
The plan describes important near-term actions that FDA is taking to modernize use of technology—computer hardware, software, data, and analytics—to advance FDA’s public health mission.
Fostering Drug Competition
Increasing the availability of generic drugs helps to create competition in the marketplace, helping make treatment more affordable and increasing access to healthcare for more patients.
Combating the Opioid Crisis
FDA takes actions to combat prescription opioid abuse.
Recent Press Announcements
Feb 04
FDA Takes Significant Step in Coronavirus Response Efforts, Issues Emergency Use Authorization for the First 2019 Novel Coronavirus Diagnostic
Feb 03
FDA and FTC Announce New Efforts to Further Deter Anti-Competitive Business Practices, Support Competitive Market for Biological Products to Help Americans
Recalls, Market Withdrawals, & Safety Alerts
The FDA provides information gathered from press releases and other public notices about certain recalls of FDA-regulated products. Not all recalls have press releases or are posted on this website
Feb 04
Cargill Conducts Voluntary Recall of a Single Lot of Nutrebeef® Transition Pellet Due to Elevated Levels of Monesin
Animal & Veterinary, Food & Beverages
Jan 31
Efficient Laboratories, Inc. Issues Voluntary Nationwide Recall of Rompe Pecho EX, Rompe Pecho CF, and Rompe Pecho MAX due to Microbial Contamination
Drugs
Jan 31
Salud Natural Entrepreneur Inc. Recalls Nopalina Flax Seed Fiber Powder and Nopalina Flax Seed Fiber Capsules Because of Possible Health Risk (Updated Lot Number Information)
Dietary Supplements, Food & Beverages
FDA VOICES: PERSPECTIVES FROM FDA EXPERTS
Shedding More Light on Sunscreen Absorption
New research adds to our understanding of sunscreens
FDA Harnesses Technology and Collaboration to Support Rare Disease Product Development
Announcing an Orphan Drug Technology Modernization effort and the 2020 FDA Rare Disease Day meeting
Outbreaks Emphasize the Importance of Implementing Produce Safety Standards
Our commitment to advancing produce safety is unwavering.
Recently Published Guidances
Feb 04
Mucopolysaccharidosis Type III (Sanfilippo Syndrome): Developing Drugs for Treatment Guidance for Industry
Biologics, Drugs
Feb 03
Small Entity Compliance Guide: Revision of the Nutrition and Supplement Facts Labels
Dietary Supplements, Food & Beverages
Feb 03
Promotional Labeling and Advertising Considerations for Prescription Biological Reference and Biosimilar Products Questions and Answers Guidance for Industry